Who owns Tarsus Pharmaceuticals, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TARS from SEC Form 13F filings across 256 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 256 institutions disclosed 47.3M shares of Tarsus Pharmaceuticals, Inc. worth $2.98B — about 109% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
256
13F holders
$2.98B
value, 2026 filers
109%
of shares outstanding (47.3M sh)
39
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TARS's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.9M | $242.7M | 0.0% | 8.9% | +8.5% |
| 2 | Deep Track Capital, LP | 3.7M | $230.8M | 3.4% | 8.5% | +1.9% |
| 3 | RTW INVESTMENTS, LP | 3.4M | $211.3M | 1.8% | 7.7% | +0.3% |
| 4 | Jupiter Topco LLCNEW | 2.8M | $176.8M | 0.1% | 6.5% | new |
| 5 | Paradigm Biocapital Advisors LP | 2.8M | $174.7M | 3.3% | 6.4% | +8.3% |
| 6 | MORGAN STANLEY | 1.8M | $115.0M | 0.0% | 4.2% | -6.0% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $112.9M | 0.0% | 4.1% | +1.8% |
| 8 | JENNISON ASSOCIATES LLC | 1.7M | $104.7M | 0.1% | 3.8% | -2.8% |
| 9 | TANG CAPITAL MANAGEMENT LLC | 1.6M | $98.7M | 4.5% | 3.6% | +31.9% |
| 10 | MILLENNIUM MANAGEMENT LLC | 1.4M | $89.8M | 0.0% | 3.3% | +152.8% |
| 11 | BANK OF AMERICA CORP /DE/ | 1.2M | $75.1M | 0.0% | 2.7% | -0.1% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $69.6M | 0.0% | 2.5% | -1.4% |
| 13 | STATE STREET CORP | 1.1M | $67.5M | 0.0% | 2.5% | +9.7% |
| 14 | Vestal Point Capital, LP | 1.1M | $66.1M | 1.5% | 2.4% | +425.0% |
| 15 | Assenagon Asset Management S.A. | 947,495 | $59.6M | 0.1% | 2.2% | -26.0% |
| 16 | Invesco Ltd. | 785,808 | $49.5M | 0.0% | 1.8% | +5.8% |
| 17 | GOLDMAN SACHS GROUP INC | 742,693 | $46.7M | 0.0% | 1.7% | +68.9% |
| 18 | Frazier Life Sciences Management, L.P. | 728,644 | $45.9M | 1.0% | 1.7% | 0.0% |
| 19 | D. E. Shaw & Co., Inc. | 710,559 | $44.7M | 0.0% | 1.6% | -10.2% |
| 20 | FMR LLC | 672,949 | $42.4M | 0.0% | 1.6% | -8.2% |
| 21 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 607,272 | $38.2M | 0.1% | 1.4% | +21.5% |
| 22 | Clearbridge Investments, LLC | 549,387 | $34.6M | 0.0% | 1.3% | +0.7% |
| 23 | TORONTO DOMINION BANK | 510,253 | $32.1M | 0.0% | 1.2% | 0.0% |
| 24 | LORD, ABBETT & CO. LLC | 479,266 | $30.2M | 0.1% | 1.1% | -43.1% |
| 25 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/NEW | 427,008 | $26.9M | 0.0% | 1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.